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Amsterdam, the Netherlands; and West Point, PennsylvaniaOBJECTIVES This study hypothesized that 1H magnetic resonance spectroscopy (1H-MRS) can
identify carotid plaque cholesteryl ester in vivo in humans.
BACKGROUND Liquid phase cholesteryl ester comprises a major fraction of atherosclerotic pla-
que, and its abundance is associated with plaque rupture and atherothrombosis. A noninvasive imag-
ing technique to detect liquid cholesteryl ester that has been applied ex vivo is now demonstrated
in vivo.
METHODS 1H-MRS scans were obtained of carotid plaques of 35 subjects at 3.0 T. Turbo spin echo,
black blood, T1-weighted images were acquired for localization. Spectra were acquired using a
2-dimensional point resolved spectroscopy sequence: repetition time/echo time ¼ 1,100/30 ms, 5-mm
slice thickness, 8  8-cm ﬁeld of view, 16  16 matrix size, and 13-min acquisition time. Saturation bands
were placed around the artery. Resonance of methylene protons and allylic methylene protons were
assigned to 1.2 ppm and 2.0 ppm. The 2.0:1.2 ppm ratio was calculated to reﬂect the ratio of the fatty
acid composition of plaque cholesteryl ester to that of triglycerides of perivascular tissue. We obtained
spectra of lipid standards as a reference.
RESULTS Our 1H-MRS data showed typical spectra of cholesteryl ester mixed with triglycerides, with
intense resonance from methylene (1.2 ppm) and allylic methylene (2.0 ppm) protons. The average
2.0:1.2 ppm ratio was 0.10  0.03. The 2.0:1.2 ppm ratio correlated with the plaque tissue volume to peri-
vascular tissue volume ratio (Spearman rho ¼ 0.55, p ¼ 0.02), suggesting that more 1H-MRS signal was
obtained from cholesteryl ester when the 1H-MRS voxel comprised more plaque tissue. Repeat 1H-MRS
scans in 4 subjects showed an intraclass correlation coefﬁcient of 0.92 (95% prediction intervals: 0.40 to
0.99), indicating good reproducibility. Seventeen of the 35 1H-MRS spectra were of adequate quality for
analysis.
CONCLUSIONS In vivo image-guided 1H-MRS for detection of liquid phase cholesteryl ester in
carotid atherosclerotic plaques in humans is feasible. (J Am Coll Cardiol Img 2013;6:1277–84) ª 2013
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CA B B R E V I A T I O N S
A N D A C R O N YM S
1H-MRS = 1H magnetic
resonance spectroscopy
MRI = magnetic resonance
imaging
TE = echo time
TR = repetition time
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1278holesteryl ester in the liquid phase com-
prises a major portion of the lipid-rich core
of atherosclerotic plaques, and its abun-
dance has been associated with plaque
rupture and formation of atherothrombosis (1). The
unique lipid composition of atheroma, with a high
proportion of cholesteryl ester relative to other
lipids, is mainly a result of the inﬁltration and
retention of cholesterol carrying low-density lipo-
protein that is transported through injured endo-
thelium and penetrates the vascular tissue (2).
Furthermore, macrophages ingest and digest lipo-
protein cholesterol and store it as cholesteryl ester
in their cytoplasm as droplets (1). Reversibility of
atherosclerotic lesions is thought to be limited by
removal of cholesteryl esters in the liquid phase,
whereas dissolution of crystalline deposits are
thought to be minimal (1).See page 1285Quantiﬁcation of liquid cholesteryl ester
content of plaque is therefore valuable for
the assessment of plaque vulnerability and
for monitoring the effects of antiathero-
sclerotic drugs. However, techniques that
permit this type of quantiﬁcation on
a molecular level in vivo in humans are
currently not available. Imaging techni-
ques such as ultrasound and magneticresonance imaging (MRI) are quite capable of
assessing plaque size (3). In addition, MRI can
identify plaque components, such as lipid-rich tis-
sue, hemorrhage, and calciﬁcations, through signal
intensity differences elicited by varying contrast-
weighted sequences (3). Nonetheless, the sensiti-
vity of the detection of plaque cholesterol content is
limited because lipid regions are inhomogeneous.
Furthermore, lipid regions may contain crystals of
cholesterol and are sometimes proximal to regions of
calciﬁcation, both of which create a signal void in
proton MRI.
Image-guided proton 1H magnetic resonance
spectroscopy (1H-MRS) has the potential to detect
liquid cholesteryl ester noninvasively without the
need for radiation or additional contrast agents
(4–7). 1H-MRS gives a spectrum of signals from all
proton resonances in a given volume, thus affording
detection of speciﬁc chemical components through
their inherent frequency shift relative to water. On
image-guided 1H-MRS, a magnetic resonance im-
age can be used to image and localize plaque. Proton
spectra can then be collected from these plaques, sothat the speciﬁc proton resonances of lipid compo-
nents in a liquid state, including cholesteryl ester,
can be identiﬁed (4–7). A major advantage is that a
change in the composition of the plaque could
be evaluated without (and potentially preceding)
changes in plaque volume.
The aim of our study was to develop a noninvasive
image-guided 1H-MRS approach that enables
quantiﬁcation of plaque cholesteryl ester content.
First, we assessed 1H-MRS signals from lipid stan-
dards containing triglycerides and cholesteryl ester
to characterize their spectrum. We then performed
in vivo 1H-MRS measurements of patients with
atherosclerotic lesions in the carotid arteries.
METHODS
Study design. 1H-MRS spectra of pure cholesteryl
ester and triglycerides as well as mixtures of both
lipids were obtained. These data were acquired at
Merck Research Laboratories, Rahway, New Jersey.
MRI (3.0-T) and 1H-MRS of atherosclerotic
plaques in carotid arteries of 35 patients were per-
formed at the Academic Medical Center, Amster-
dam, the Netherlands. The study protocol was
reviewed and approved by the institutional review
board, and all subjects gave written informed con-
sent. Inclusion criteria were 18 to 75 years of age
and carotid artery stenosis between 30% and 70%
on duplex ultrasound. Exclusion criteria were pre-
vious or planned carotid surgery or any contraindi-
cation to MRI. The presence of cardiovascular risk
factors and the use of medication were assessed by
questionnaire. Brachial artery blood pressures were
measured using an oscillometric blood pressure de-
vice (Omron 705IT, Omron Healthcare Inc., Lake
Forest, Illinois). Weight and length were measured
to calculate body mass index. Venous blood samples
were obtained after overnight fasting to assess
plasma total cholesterol, high-density lipoprotein
cholesterol, and triglyceride levels. Low-density li-
poprotein cholesterol levels were calculated using
the Friedewald equation.
Lipid standard 1H-MRS. To characterize the
1H-MRS spectra, image-guided 1H-MRS was per-
formed on puriﬁed triglycerides (glyceryl trioleate),
and cholesteryl ester (cholesteryl linoleate, Sigma-
Aldrich, St. Louis, Missouri), as well as mixtures
of both lipids. The lipid standards were scanned
with an 11.7-T 500 wide-bore MRI system (Bruker
NMR, Inc., Billerica, Massachusetts) with a vertical
bore diameter of 89 mm. Spectra were acquired
with a point resolved spectroscopy sequence. Scan
parameters were repetition time (TR)/echo time
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1279(TE) ¼ 5,000/10 ms, 2  2  2 to 2  4  2 mm3
voxel size, and 256 excitations. The line width was
100 Hz. No water suppression was used because
there was no water content in the lipid standards.
In vivo carotid MRI and 1H-MRS. MRI scans were
performed using a 3.0-T whole-body scanner (3.0
Tesla Intera, Philips Medical Systems, Best, the
Netherlands), using an 8-element carotid coil (Phi-
lips Medical Systems). For localization of the carotid
plaques, axial T1-weighted image stacks were ac-
quired at late diastole (retrospective electrocardio-
graphic gating). Sequence parameters were turbo
spin echo, double inversion recovery black blood
prepulse, 2 signal averages, 8-ms TE, TR according
to heart rate (w800 to 900 ms), 3-mm slice thick-
ness, 240 matrix size, 60  60-mm ﬁeld of view,
0.25  0.25-mm noninterpolated pixel size, and
active fat suppression (spectral abiabatic inversion
recovery). Acquisition time of the 1H-MRS spectra
was approximately 13 min, and total scan time
including the T1-weighted imaging was w20 min.
MRI analysis was performed using semi-
automated measurement software (VesselMass,
Leiden University Medical Center, Leiden, the
Netherlands). We drew the lumen and outer wall
boundaries in the 2 slices (each with a 3-mm slice
thickness) that were located where the 1H-MRS
voxel was located. The localization of the 1H-MRSFigure 1. 1H-Magnetic Resonance Spectrum Localization and Analy
T1-weighted 3.0-T magnetic resonance image (left) and the 1H-magneti
methylene (CH2) peak and the allylic methylene (CH2-CH¼CH-CH2) peavoxel was based on the axial T1-weighted image
stacks, which enabled us to identify which
T1-weighted slices were located in the 1H-MRS
voxel. We measured the lumen area (mm2) and
wall area (mm2), which we multiplied by 5 mm
(the slice thickness of the MRS voxel) to calculate
lumen volume (mm3) and wall volume (mm3).
Subsequently, perivascular tissue volume (mm3)
was calculated by subtracting the lumen volume
and wall volume from the volume of the MRS
voxel (which was 500 mm3). After the 1H-MRS
scan was performed, we obtained another
T1-weighted slice located in the 1H-MRS voxel to
assess whether the subject had moved during the
1H-MRS scan.
Image-guided 1H-MRS acquisition was per-
formed on a 3.0-T whole-body scanner using an
8-element carotid coil (3.0 Tesla Intera, Philips
Medical Systems). Spectra with and without water
suppression were obtained. Two-dimensional
chemical shift imaging data were collected using
a point resolved spectroscopy sequence with
the following parameters: TR ¼ 1,100 ms,
TE ¼ 30 ms, 5-mm slice thickness, 16  16 matrix
size, 8 8-cm ﬁeld of view, 13-min acquisition time,
1 acquisition. Each 1H-MRS voxel was 5  5 
5 mm (125 mm3). For all analyses, 4 voxels (total
volume ¼ 500 mm3) covering the carotid arterysis
c resonance spectrum (right) of a carotid atherosclerotic plaque. The
k were ﬁtted at 1.2 ppm and 2.0 ppm, respectively.
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1280plaque were selected for further analysis (Fig. 1).
To minimize patient movement during the
1H-MRS scan, we instructed the subjects not to
move during the scan, and we reminded them of this
by repeating this instruction just before starting the
MRS sequence. The 4 voxels (total volume ¼ 500
mm3) covering the carotid artery plaque that were
selected for further analysis (Fig. 1) were processed
using the freely available 3DiCSI package (version
1.9.11, Columbia University, New York, New
York). Chemical shifts were reported using water as
the internal standard at 4.65 ppm. Average spectra
were then processed using specialized computer
software (jMRUI 2.2, MRUI, Leuven, Belgium)
(8). Three peaks were line ﬁtted: methyl (CH3) at
0.8 ppm, methylene (CH2) at 1.2 ppm, and allylic
methylene (CH2-CH¼CH-CH2) at 2.0 ppm
(Fig. 1). We used water-suppressed spectra to mea-
sure the 0.8-ppm, 1.2-ppm, and 2.0-ppm peaks.
In a subset of 4 subjects, we performed initial and
repeat 1H-MRS scans with at least 1 week between
scans to assess interscan reproducibility.
Statistical analysis. Continuous variables are ex-
pressed as mean  SD, unless otherwise speciﬁed.
Spearman rho values were calculated to assess
the correlation between the allylic methylene
(2.0 ppm) to methylene (1.2 ppm) ratio and serum
total cholesterol serum triglycerides, as well as the
plaque volume to perivascular tissue volume ratio.
Spearman rho was used because the data was not
normally distributed. The agreement between
initial and repeat 1H-MRS scans within patients
was assessed by the intraclass correlation co-
efﬁcients (r), the SD of the paired differences, and
the repeatability coefﬁcient. All statistics were
performed with SPSS version 19.0 (SPSS Inc.,
Chicago, Illinois).Figure 2. 1H-Magnetic Resonance Spectra of Lipid Standards With
In the plot on the right, the merged values of the peaks of 2.0 ppm and
at lower ﬁeld strength at lower spectral resolution. CE ¼ cholesteryl esRESULTS
Lipid phantom results. 1H-MRS spectra of lipid
standards were obtained of 5 different mixtures of
triglycerides and cholesteryl ester. The allylic
methylene (CH2-CH¼CH-CH2 at 2.0 ppm) to
methylene (CH2 at 1.2 ppm) ratio shows an increase
as the amount of cholesteryl ester increases relative
to triglycerides (Fig. 2). Note that this increase re-
mains present if the peaks of 2.0 ppm and 2.2 ppm
are merged together as will be the case at lower ﬁeld
strength at lower spectral resolution. The absolute
values of the 2.0 ppm to 1.2 ppm ratio of the lipid
phantoms cannot be compared with the absolute
values of the in vivo 2.0 ppm to 1.2 ppm ratio
because different TEs were used in vivo and ex vivo
and pure glyceryl trioleate and cholesteryl linoleate
were used, whereas, in vivo, a mixture of different
fatty acid chains exists.
In vivo 1H-MRS results. Carotid MRI and 1H-MRS
scans were obtained of 35 subjects with carotid
atherosclerosis, deﬁned as 30% to 70% carotid ste-
nosis on ultrasound duplex. Of the 35 1H-MRS
spectra, 17 spectra (49%) were of adequate quality
for analysis. Patient characteristics of the 17 patients
are shown in Table 1. The methyl (0.8 ppm),
methylene (1.2 ppm), and allylic methylene (2.0
ppm) peaks were line ﬁtted. The methyl (0.8 ppm)
peak proved to be intricate to ﬁt properly. Because
of the limited spectral resolution the methyl peak
(0.8 ppm) often partially blended into the methylene
(1.2 ppm) peak and because of this, these ﬁts were
unreliable. Of the allylic methylene (2.0 ppm) and
methylene (1.2 ppm) peaks, we were able to obtain
good quality ﬁts in 17 of 35 spectra. The median
allylic methylene (2.0 ppm) to methylene (1.2 ppm)
ratio was 0.10 (interquartile range: 0.08 to 0.12).Various Mixtures of TG and CE
2.2 ppm are used to calculate the 2.0:1.2 ppm ratio as will be the case
ter; TG ¼ triglycerides.
Table 1. Patient Characteristics (N [ 17)
Characteristics
Age, yrs 71 (7)
Male 12 (71)
Body mass index, kg/m2 26 (3)
Smokers 2 (12)
Statin users 13 (76)
Medical history
Hypertension 10 (59)
Diabetes 5 (29)
Transient ischemic attack/stroke 9 (53)
Coronary heart disease 4 (24)
Blood pressure, mm Hg
Systolic 145 (23)
Diastolic 74 (12)
Biochemistry, mmol/l
Total cholesterol 4.40 (0.92)
Low-density lipoprotein-cholesterol 2.47 (0.90)
High-density lipoprotein-cholesterol 1.43 (0.46)
Triglycerides 0.93 (0.81–1.39)
Fasting glucose 5.95 (2.79)
C-reactive protein 6.20 (5.80–6.30)
3.0-T magnetic resonance imaging
Lumen area, mm2 249 (177–381)
Mean wall area, mm2 429 (361–614)
Normalized wall index 0.58 (0.53–0.76)
Mean wall thickness, mm 1.70 (1.45–2.31)
Values are n (%) or median (interquartile range).
Figure 3. Correlation Between the 2.0:1.2 ppm Ratio and the
Plaque Volume/PVT Volume Ratio
With an increasing volume of plaque tissue relative to perivascular
tissue (PVT) the 2.0:1.2 ppm ratio increases, indicating an
increasing amount of cholesteryl ester relative to triglycerides.
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 6 , N O . 1 2 , 2 0 1 3 Duivenvoorden et al.
D E C E M B E R 2 0 1 3 : 1 2 7 7 – 8 4 MR Spectroscopy in Human Atherosclerosis
1281The volume of tissue from which we obtained the
spectra was composed of blood in the lumen, pla-
que, and perivascular tissue. We assessed whether
serum lipids inﬂuenced our 1H-MRS measurement.
We did not ﬁnd a correlation between the allylic
methylene (2.0 ppm) to methylene (1.2 ppm) ratio
and serum total cholesterol (Spearman rho ¼ 0.43,
p ¼ 0.10) or serum triglycerides (Spearman
rho ¼ 0.27, p ¼ 0.31), indicating that serum lipids
did not inﬂuence our 1H-MRS spectra. We also
assessed whether our 1H-MRS measurement was
inﬂuenced by the amount of plaque volume (cho-
lesteryl ester–rich tissue) relative to the perivascular
tissue volume (triglyceride-rich tissue). Figure 3
shows that there is a signiﬁcant correlation be-
tween the allylic methylene (2.0 ppm) to methylene
(1.2 ppm) ratio and plaque volume to perivascular
tissue volume ratio.
Seven subjects were willing to visit us twice, and
in these subjects, initial and repeat 1H-MRS scanswere obtained, of whom 4 subjects had analyzable
data of both the initial and repeat scan. In this
subset of 4 subjects we assessed the agreement be-
tween initial and repeat 1H-MRS scans within pa-
tients, and the intraclass correlation coefﬁcient (r)
was 0.92 (95% prediction intervals: 0.40 to 0.99),
the SD of the paired differences was 0.011, and the
reproducibility coefﬁcient was 0.022 (95% limits of
agreement: 0.017 to 0.029), for the allylic meth-
ylene (2.0 ppm) to methylene (1.2 ppm) ratio,
indicating good reproducibility.
D I SCUSS ION
The present study shows for the ﬁrst time that
image-guided 1H-MRS of carotid atherosclerotic
plaques is feasible in vivo in humans. We success-
fully quantiﬁed the allylic methylene (2.0 ppm) to
methylene (1.2 ppm) ratio, which reﬂects the ratio
of the fatty acid composition of plaque cholesteryl
ester to that of perivascular tissue triglyceride.
Furthermore, the allylic methylene (2.0 ppm) to
methylene (1.2 ppm) ratio was shown to have good
reproducibility. 1H-MRS of plaques still has a
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1282limited spatial resolution and is technically chal-
lenging, illustrated by the fact only 49% of the ob-
tained 1H-MRS spectra was of adequate quality for
analysis. The present data imply that in vivo in
humans, 1H-MRS of carotid artery plaques offers a
promising and valuable tool that can speciﬁcally
identify liquid cholesteryl ester through its speciﬁc
proton resonances.
The type of lipids and their physical properties in
atherosclerotic lesions have been well investigated
over the past decades (1). Cholesterol, cholesteryl
ester, and phospholipids are known to accumulate in
fatty streaks and plaques, whereas triglyceride
accumulation does not occur (1). As early as the
1960s, it was recognized that a large portion of
lipids in atherosclerotic lesions accumulate in the
form of intracellular droplets. Lang and Insull (9)
showed that the droplets contained about one-half
of the lipids in the lesions. Furthermore, the
composition of the lipids in the droplets was
remarkably uniform and comprised 94.9% choles-
teryl esters, 1.7% free cholesterol, 1.0% phospho-
lipids, and 2.4% triglycerides. Thus, cholesteryl ester
in the liquid phase in intracellular droplets makes up
a large portion of the plaque lipid content. More-
over, the reversibility of atherosclerotic lesions likely
depends on removal of these liquid cholesteryl es-
ters, in contrast to crystalline cholesterol deposits,
which are thought to be trapped within the plaque
(1). Therefore, a technique that enables direct and
unequivocal identiﬁcation of cholesteryl ester in the
liquid state in plaque can provide important infor-
mation on plaque phenotype and would enable
speciﬁc investigation of the effect of antiathero-
sclerotic interventions aimed at removing cholesteryl
esters from plaques.
Based on the ﬁndings by Lang and Insull (9), the
1H-MRS spectra of atherosclerotic plaque are ex-
pected to be derived for 95% of cholesteryl esters
and for only a small amount of triglycerides (phos-
pholipids are known not to show resonance). The
latter contrasts with our observation. Based on the
characteristics of the lipid phantoms and our in vivo
spectra, we estimate that in addition to cholesteryl
ester, the signal from triglycerides does contribute
signiﬁcantly to the in vivo spectra. This apparent
discrepancy most likely pertains to the fact that the
volume of tissue from which we obtained the in vivo
spectra does not only contain plaque, but also a
substantial amount of perivascular tissue. Peri-
vascular tissue is known to be composed mainly of
adipocytes in which triglyceride droplets are stored
(10). The fatty acyl chains of triglycerides in adipose
tissue are 50% comprised of oleate, 12% of linoleate,25% of palmitic acid, and to a lesser extent, of other
fatty acyl chains (11). In contrast, the fatty acyl
chains of the cholesteryl esters in plaques comprise
w35% oleate, 35% linoleate, 14% palmitic acid, and
to a lesser extent other fatty acyl chains (12). Oleate
(the carbon-to-double bond ratio of 18:1) consists
of a single allylic methylene (CH2-CH¼CH-CH2)
and 14 methylenes (CH2). Linoleate (18:2) consists
of 2 allylic methylenes and 12 methylenes. Palmitic
acid (16:0) has 14 methylenes but does not have an
allylic methylene group. The markedly different
composition of fatty acyl chains of plaque cholesteryl
ester and perivascular triglycerides results in a lower
allylic methylene-to-methylene ratio in perivascular
triglycerides as opposed to plaque cholesteryl ester.
The contribution of serum lipids to the spectra is
minimal. We estimate that in the lumen volume
included in the 1H-MRS voxel, the amount of lipids
approximates 0.5 mg total serum cholesterol and 0.3
mg serum triglycerides. This is negligible compared
with the amount of cholesteryl ester in plaques,
which exceed an order of magnitude of 4 to 28 mg
(9). Therefore, we expect the impact of serum lipids
on the 1H-MRS spectra to be minimal. Further-
more, we did not ﬁnd a relationship between serum
lipid levels and the allylic methylene (2.0 ppm) to
methylene (1.2 ppm) ratio.
MRS studies of ex vivo atherosclerotic lesions
have been performed with both 13C-MRS and
1H-MRS (4–7,13–16). 13C-MRS studies showed
that the spectra obtained from plaque reﬂect almost
exclusively cholesteryl ester in the liquid state
(13–16). Lipids in liquid crystalline and crystalline
phases, such as phospholipids and cholesterol were
detected by magic angle spinning 13C-MRS (13–16).
Furthermore, 4 studies have performed 1H-MRS
of plaques ex vivo (4–7). Zajicek et al. (4) performed
1H-MRS at 8.481-T on 8 ex vivo plaques that were
scanned at 37C and compared the spectra with
plaque lipid content assessed by quantitative thin-
layer chromatography, gas-liquid chromatography,
and histology. They showed that the 1H-MRS
spectra largely reﬂect the presence of cholesteryl
esters in the isotropic liquid phase. Maynor et al. (5)
reported a 1H-MRS study at 7.0-T using chemical
shift imaging on 13 atherosclerotic lesions and also
showed that plaques reveal a typical cholesteryl ester
spectrum that differed from the triglyceride spectrum
of adipose tissue.
Pearlman et al. (6) performed 1H-MRS of ex vivo
human plaques at 6.342-T, 8.481-T, and 11.75-T
and investigated the relationship of temperature
and the spectral resonances of plaque lipids. They
found that the 1H-MRS signals are derived of a
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1283mixture of cholesteryl esters, whose liquid crystalline
to isotropic ﬂuid phase transition is near body
temperature. Ruberg et al. (7) acquired 1H-MRS at
11.7-T of 10 human carotid endarterectomy speci-
mens. They obtained MRS spectra from 1-mm3
voxels, localized to plaque regions that were either
lipid rich or lipid poor and showed that the spectra
from lipid-rich areas showed much more intense
cholesteryl ester resonances than did lipid-poor re-
gions. Our in vivo ﬁndings corroborate the previous
ex vivo 1H-MRS studies, as our data also showed
typical spectra of mixed cholesteryl ester and tri-
glyceride, with resonance from the methyl (0.8
ppm), methylene (1.2 ppm), and allylic methylene
(2.0 ppm) protons. Furthermore, Ruberg et al. (7)
also performed 1H-MRS on lipid standards of
pure cholesteryl ester, pure triglycerides, and pure
phospholipids and showed identical proton spectra
compared with our pure cholesteryl ester, pure tri-
glyceride spectra. No resonances from the phos-
pholipids were observed, which was expected
because of their highly restricted and anisotropic
motion in the liquid crystalline multilayer.
Study limitations. First, with our image-guided
1H-MRS approach, spectra were obtained of a vol-
ume that contained blood in the lumen of the vessel,
plaque tissue, and perivascular tissue. Due to limited
resolution and the point spread function of the
chemical shift imaging sequence, the proton spectra
could not be obtained of only plaque tissue. None-
theless, plaque tissue is known to have abundant
cholesteryl ester content and very little triglycerides,
whereas the opposite is true for perivascular tissue.
Thus, the contribution of the fatty acids of choles-
teryl ester to the signal is likely to be derived spe-
ciﬁcally from plaque tissue. Second, the 1H-MRS
spectra do not permit an absolute quantiﬁcation of
the amount of cholesteryl ester to be determined.
Instead 1H-MRS spectra provide the amount of
cholesteryl ester in relation to the amount of tri-
glycerides. Because this relies on the amount of
plaque tissue and perivascular tissue included in
the volume from which the spectrum is ob-
tained, comparison between subjects is cumbersome.Nonetheless, our current approach is suitable for
longitudinal comparison within subjects, as long as
the volume from which the 1H-MRS spectrum is
obtained is located in the same location. The fact
that our measurement showed good reproducibility
shows that reproducible localization of image-
guided 1H-MRS is feasible.
The third limitation is that it proved to be
difﬁcult to obtain good quality 1H-MRS spectra.
About one-half of the spectra were of poor quality.
This could be due to various factors, such as sepa-
rating the signal of methylene and allylic methylene
protons, unmet shimming requirements, signal loss
due to the deep localization of the carotid arteries,
and patient movement. For future studies we need
to optimize the 1H-MRS methods to improve the
quality of the spectra.CONCLUS IONS
The present study shows for the ﬁrst time that
image-guided 1H-MRS of carotid atherosclerotic
plaques is feasible in vivo in humans and can
possibly detect cholesteryl ester in the liquid phase.
The ratio of the resonance of the allylic methylene
(2.0 ppm) to methylene (1.2 ppm) protons reﬂects
the fatty acid composition of plaque cholesteryl ester
relative to that of perivascular triglycerides in the
scanned volume. Our image-guided 1H-MRS
method showed good reproducibility. Future studies
are needed to further address the limitations of the
technique, improve the quality of the 1H-MRS
spectra, and enable quantiﬁcation of liquid-phase
cholesteryl ester.Acknowledgment
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